The North America Genomics Market would witness market growth of 17.3% CAGR during the forecast period (2021-2027).
Genomics has been scientifically demonstrated to be effective in disease prevention, management, and therapy. Over the last few years, the healthcare environment has shifted from traditional treatment methods to precision medicine, and this movement has been accelerated by extraordinary clinical qualities. Whole-genome sequencing has emerged as a valuable tool for diagnosing life-threatening disorders like cancer.
The ongoing trends of the market are the expanding government support and increased number of genomics studies, reducing sequencing costs, and more genomics applications. The genomics industry is expected to increase at an exponential rate due to important genetic advances and their applications in a variety of fields, including intragenomic phenomena such as epistasis, heterosis, pleiotropy, and other correlations between alleles and locations inside the genome. Bioengineering and synthetic biology applications are expected to play a key role in boosting the growth of the genomics market.
North America is witnessing a massive adoption of new sequencing technology and a shift toward tailored medications. In addition, government assistance is critical. For example, the Biden Administration announced a USD 1.7 billion investment to Fight COVID-19 Variants in April 2021, with USD 1 billion going to expand genomic sequencing and USD 400 million going to support innovation initiatives like the launch of new innovative centers of excellence in genomic epidemiology.
The US market dominated the North America Genomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $19,989 million by 2027. The Canada market is expected to witness a CAGR of 20% during (2021 - 2027). Additionally, The Mexico market would experience a CAGR of 18.9% during (2021 - 2027).
Based on Product & Service, the market is segmented into Consumables, Systems & Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Diagnostics, Agriculture & Animal Research and Others. Based on End User, the market is segmented into Hospitals & Clinics, Research Centers and Academic & Government Institutes, Pharmaceutical & Biotechnology Companies and Others. Based on Technology, the market is segmented into Sequencing, PCR, Nucleic Acid Extraction & Purification, Microarray, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Genomics Market is Estimated to reach $68.9 Billion by 2027, at a CAGR of 17.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Creative Biogene, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Eurofins Scientific Group, Qiagen N.V., and New England BioLabs, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product & Service
- Consumables
- Systems & Software and
- Services
By Application
- Drug Discovery & Development
- Diagnostics
- Agriculture & Animal Research and
- Others
By End User
- Hospitals & Clinics
- Research Centers and Academic & Government Institutes
- Pharmaceutical & Biotechnology Companies and
- Others
By Technology
- Sequencing
- PCR
- Nucleic Acid Extraction & Purification
- Microarray, and
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Creative Biogene
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Hoffmann-La Roche Ltd.
- Eurofins Scientific Group
- Qiagen N.V.
- New England BioLabs, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genomics Market, by Product & Service
1.4.2 North America Genomics Market, by Application
1.4.3 North America Genomics Market, by End User
1.4.4 North America Genomics Market, by Technology
1.4.5 North America Genomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Jan – 2021, Dec) Leading Players
Chapter 4. North America Genomics Market by Product & Service
4.1 North America Consumables Market by Country
4.2 North America Systems & Software Market by Country
4.3 North America Services Market by Country
Chapter 5. North America Genomics Market by Application
5.1 North America Drug Discovery & Development Market by Country
5.2 North America Diagnostics Market by Country
5.3 North America Agriculture & Animal Research Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Genomics Market by End User
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Research Centers and Academic & Government Institutes Market by Country
6.3 North America Pharmaceutical & Biotechnology Companies Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Genomics Market by Technology
7.1 North America Sequencing Market by Country
7.2 North America PCR Market by Country
7.3 North America Nucleic Acid Extraction & Purification Market by Country
7.4 North America Microarray Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Genomics Market by Country
8.1 US Genomics Market
8.1.1 US Genomics Market by Product & Service
8.1.2 US Genomics Market by Application
8.1.3 US Genomics Market by End User
8.1.4 US Genomics Market by Technology
8.2 Canada Genomics Market
8.2.1 Canada Genomics Market by Product & Service
8.2.2 Canada Genomics Market by Application
8.2.3 Canada Genomics Market by End User
8.2.4 Canada Genomics Market by Technology
8.3 Mexico Genomics Market
8.3.1 Mexico Genomics Market by Product & Service
8.3.2 Mexico Genomics Market by Application
8.3.3 Mexico Genomics Market by End User
8.3.4 Mexico Genomics Market by Technology
8.4 Rest of North America Genomics Market
8.4.1 Rest of North America Genomics Market by Product & Service
8.4.2 Rest of North America Genomics Market by Application
8.4.3 Rest of North America Genomics Market by End User
8.4.4 Rest of North America Genomics Market by Technology
Chapter 9. Company Profiles
9.1 Creative Biogene
9.1.1 Company Overview
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Illumina, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisition and Mergers:
9.4 Bio-Rad laboratories, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Agilent Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.5.3 Acquisition and Mergers:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.10. New England BioLabs, Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:
TABLE 1 North America Genomics Market, 2017 - 2020, USD Million
TABLE 2 North America Genomics Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Genomics Market
TABLE 4 Product Launches And Product Expansions– Genomics Market
TABLE 5 Acquisition and Mergers– Genomics Market
TABLE 6 North America Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 7 North America Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 8 North America Consumables Market by Country, 2017 - 2020, USD Million
TABLE 9 North America Consumables Market by Country, 2021 - 2027, USD Million
TABLE 10 North America Systems & Software Market by Country, 2017 - 2020, USD Million
TABLE 11 North America Systems & Software Market by Country, 2021 - 2027, USD Million
TABLE 12 North America Services Market by Country, 2017 - 2020, USD Million
TABLE 13 North America Services Market by Country, 2021 - 2027, USD Million
TABLE 14 North America Genomics Market by Application , 2017 - 2020, USD Million
TABLE 15 North America Genomics Market by Application , 2021 - 2027, USD Million
TABLE 16 North America Drug Discovery & Development Market by Country, 2017 - 2020, USD Million
TABLE 17 North America Drug Discovery & Development Market by Country, 2021 - 2027, USD Million
TABLE 18 North America Diagnostics Market by Country, 2017 - 2020, USD Million
TABLE 19 North America Diagnostics Market by Country, 2021 - 2027, USD Million
TABLE 20 North America Agriculture & Animal Research Market by Country, 2017 - 2020, USD Million
TABLE 21 North America Agriculture & Animal Research Market by Country, 2021 - 2027, USD Million
TABLE 22 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 23 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 24 North America Genomics Market by End User, 2017 - 2020, USD Million
TABLE 25 North America Genomics Market by End User, 2021 - 2027, USD Million
TABLE 26 North America Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 27 North America Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 28 North America Research Centers and Academic & Government Institutes Market by Country, 2017 - 2020, USD Million
TABLE 29 North America Research Centers and Academic & Government Institutes Market by Country, 2021 - 2027, USD Million
TABLE 30 North America Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
TABLE 31 North America Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
TABLE 32 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 33 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 34 North America Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 35 North America Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 36 North America Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 37 North America Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 38 North America PCR Market by Country, 2017 - 2020, USD Million
TABLE 39 North America PCR Market by Country, 2021 - 2027, USD Million
TABLE 40 North America Nucleic Acid Extraction & Purification Market by Country, 2017 - 2020, USD Million
TABLE 41 North America Nucleic Acid Extraction & Purification Market by Country, 2021 - 2027, USD Million
TABLE 42 North America Microarray Market by Country, 2017 - 2020, USD Million
TABLE 43 North America Microarray Market by Country, 2021 - 2027, USD Million
TABLE 44 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 45 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 46 North America Genomics Market by Country, 2017 - 2020, USD Million
TABLE 47 North America Genomics Market by Country, 2021 - 2027, USD Million
TABLE 48 US Genomics Market, 2017 - 2020, USD Million
TABLE 49 US Genomics Market, 2021 - 2027, USD Million
TABLE 50 US Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 51 US Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 52 US Genomics Market by Application , 2017 - 2020, USD Million
TABLE 53 US Genomics Market by Application , 2021 - 2027, USD Million
TABLE 54 US Genomics Market by End User, 2017 - 2020, USD Million
TABLE 55 US Genomics Market by End User, 2021 - 2027, USD Million
TABLE 56 US Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 57 US Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 58 Canada Genomics Market, 2017 - 2020, USD Million
TABLE 59 Canada Genomics Market, 2021 - 2027, USD Million
TABLE 60 Canada Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 61 Canada Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 62 Canada Genomics Market by Application , 2017 - 2020, USD Million
TABLE 63 Canada Genomics Market by Application , 2021 - 2027, USD Million
TABLE 64 Canada Genomics Market by End User, 2017 - 2020, USD Million
TABLE 65 Canada Genomics Market by End User, 2021 - 2027, USD Million
TABLE 66 Canada Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 67 Canada Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 68 Mexico Genomics Market, 2017 - 2020, USD Million
TABLE 69 Mexico Genomics Market, 2021 - 2027, USD Million
TABLE 70 Mexico Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 71 Mexico Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 72 Mexico Genomics Market by Application , 2017 - 2020, USD Million
TABLE 73 Mexico Genomics Market by Application , 2021 - 2027, USD Million
TABLE 74 Mexico Genomics Market by End User, 2017 - 2020, USD Million
TABLE 75 Mexico Genomics Market by End User, 2021 - 2027, USD Million
TABLE 76 Mexico Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 77 Mexico Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 78 Rest of North America Genomics Market, 2017 - 2020, USD Million
TABLE 79 Rest of North America Genomics Market, 2021 - 2027, USD Million
TABLE 80 Rest of North America Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 81 Rest of North America Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 82 Rest of North America Genomics Market by Application , 2017 - 2020, USD Million
TABLE 83 Rest of North America Genomics Market by Application , 2021 - 2027, USD Million
TABLE 84 Rest of North America Genomics Market by End User, 2017 - 2020, USD Million
TABLE 85 Rest of North America Genomics Market by End User, 2021 - 2027, USD Million
TABLE 86 Rest of North America Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 87 Rest of North America Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 88 Key Information – Creative Biogene
TABLE 89 Key Information – Thermo Fisher Scientific, Inc.
TABLE 90 key information – Illumina, Inc.
TABLE 91 Key Information – Bio-Rad Laboratories, Inc.
TABLE 92 Key Information – Danaher Corporation
TABLE 93 key Information – Agilent Technologies, Inc.
TABLE 94 key information – F. Hoffmann-La Roche Ltd.
TABLE 95 Key Information – Eurofins Scientific Group
TABLE 96 Key Information –Qiagen N.V.
TABLE 97 Key Information – New England BioLabs, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2017, Jan – 2021, dec) Leading Players
FIG 5 Swot analysis: thermo fisher scientific, inc.
FIG 6 Recent strategies and developments: Illumina, Inc.
FIG 7 Recent strategies and developments: Bio-Rad laboratories, Inc.
FIG 8 Recent strategies and developments: Agilent Technologies, Inc.
FIG 9 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 10 Recent strategies and developments: Qiagen N.V.